Evidence map›Paper›PMID 12032775›Full record

ReviewOncogene2002

Transcriptional regulation of erythropoiesis: an affair involving multiple partners.

Alan B Cantor, Stuart H Orkin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 274 papers.

0numbers the graph read from it
0cells of the map it votes in
274citing papers in PubMed
21.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

274 citing papers in PubMed, 584 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Transcriptional Repressor BCL11A in Erythroid Cells.Advances in experimental medicine and biology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Alan B CantorDivision of Hematology/Oncology, Department of Pediatrics, Children's Hospital Boston and the Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Stuart H Orkin
Dana-Farber Cancer Institute · USHoward Hughes Medical Institute · US

Funding

FOG1 AND HEMATOPOIESISK08CA082175 · NCI · CHILDREN'S HOSPITAL BOSTON · PI CANTOR, ALAN B. · 1999 to 2003
$500k
NCI NIH HHS K08 CA 82175-02
6 · The paper itself

Abstract

Previous work has demonstrated that lineage-specific transcription factors play essential roles in red blood cell development. More recent studies have shown that these factors participate in critical protein-protein interactions in addition to binding DNA. The zinc finger transcription factor GATA-1, a central mediator of erythroid gene expression, interacts with multiple proteins including FOG-1, EKLF, SP1, CBP/p300 and PU.1. The mechanisms by which these interactions influence GATA-1 function, as well as any possible relationships between these seemingly disparate complexes, remain incompletely understood. However, several new findings have provided further insight into the functional significance of some of these interactions. Studies involving point mutants of GATA-1 have shown that a direct physical interaction between GATA-1 and FOG-1 is essential for normal human erythroid and megakaryocyte maturation in vivo. In addition, evidence has emerged that physical interaction between GATA-1 and the myeloid/lymphoid specific factor PU.1, an oncogene implicated in murine erythroleukemia, acts to functionally cross-antagonize one another. This provides a possible mechanism by which dysregulated expression of hematopoietic transcription factors leads to lineage maturation arrest in leukemias.

Indexed as

Transcription, GeneticTranslocation, GeneticAnimalsCarrier ProteinsCell LineageDNADNA-Binding ProteinsErythrocytesErythroid-Specific DNA-Binding FactorsGATA1 Transcription FactorHumansModels, BiologicalNuclear ProteinsProtein BindingProtein Structure, TertiaryTranscription FactorsCarrier ProteinsDNADNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsGATA1 protein, humanGATA1 Transcription FactorNuclear ProteinsTranscription FactorsZFPM1 protein, human

Identifiers

PMID12032775
OpenAlexW2025589527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.